Presence of Intratumoral Neutrophils Is an Independent Prognostic Factor in Localized Renal Cell Carcinoma

被引:369
作者
Jensen, Hanne Krogh [1 ]
Donskov, Frede
Marcussen, Niels
Nordsmark, Marianne
Lundbeck, Finn
von der Maase, Hans
机构
[1] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
关键词
CARBONIC-ANHYDRASE-IX; INTEGRATED STAGING SYSTEM; LONG-TERM SURVIVAL; RADICAL NEPHRECTOMY; PERIPHERAL-BLOOD; SUPPRESSOR-CELLS; PREDICT SURVIVAL; IMMUNE CELLS; CANCER; THERAPY;
D O I
10.1200/JCO.2008.18.9498
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose We have previously demonstrated a significant negative impact of intratumoral neutrophils in metastatic renal cell carcinoma. This study assessed intratumoral neutrophils in localized clear cell renal cell carcinoma (RCC). Patients and Methods The study comprised 121 consecutive patients who had a nephrectomy for localized RCC. Biomarkers (intratumoral CD8+, CD57+ immune cells, CD66b+ neutrophils, and carbonic anhydrase IX [CA IX]) were assessed by immunohistochemistry, and the relationship with clinical and histopathologic features and patient outcome was evaluated. Results The intratumoral neutrophils ranged from zero to 289 cells/mm(2) tumor tissue. The presence of intratumoral neutrophils was statistically significantly associated with increasing tumor size, low hemoglobin, high creatinine, and CA IX <= 85%. In multivariate analysis, the presence of intratumoral neutrophils (hazard ratio [HR], 3.0; 95% CI, 1.7 to 5.4; P < .0001), pT stage T3b/T4 (HR, 2.1; 95% CI, 1.2 to 3.6; P = .007), and low hemoglobin (HR, 1.8; 95% CI, 1.0 to 3.1; P = .03) were independent prognostic factors significantly associated with short recurrence-free survival. The presence of intratumoral neutrophils was also an independent prognostic factor for cancer-specific survival (HR, 3.5; 95% CI, 1.9 to 6.4; P < .0001) and overall survival (HR, 3.1; 95% CI, 1.9 to 5.0; P < .0001). Applying the prognostic value of intratumoral neutrophils to the Leibovich low-/intermediate-risk group (n = 78) showed a 5-year recurrence-free survival of 53% (95% CI, 34.6% to 71.8%; presence of intratumoral neutrophils) versus 87% (95% CI, 77.8% to 96.8%; absence of intratumoral neutrophils). The estimated concordance index was 0.74 using the Leibovich risk score and 0.80 when intratumoral neutrophils were added. Conclusion The presence of intratumoral neutrophils is a new, strong, independent prognostic factor for short recurrence-free, cancer-specific, and overall survival in localized clear cell RCC.
引用
收藏
页码:4709 / 4717
页数:9
相关论文
共 55 条
[1]   Metastatic renal carcinoma comprehensive prognostic system [J].
Atzpodien, J ;
Royston, P ;
Wandert, T ;
Reitz, M .
BRITISH JOURNAL OF CANCER, 2003, 88 (03) :348-353
[2]   Peripheral blood neutrophils as independent immunologic predictor of response and long-term survival upon immunotherapy in metastatic renal-cell carcinoma [J].
Atzpodien, Jens ;
Reitz, Martina .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (01) :129-134
[3]   The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer [J].
Bromwich, EJ ;
McArdle, PA ;
Canna, K ;
McMillan, DC ;
McNicol, AM ;
Brown, M ;
Aitchison, M .
BRITISH JOURNAL OF CANCER, 2003, 89 (10) :1906-1908
[4]  
Bui MHT, 2003, CLIN CANCER RES, V9, P802
[5]   Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy [J].
Choueiri, Toni K. ;
Garcia, Jorge A. ;
Elson, Paul ;
Khasawneh, Mohamad ;
Usman, Saif ;
Golshayan, Ali Reza ;
Baz, Rachid C. ;
Wood, Laura ;
Rini, Brian I. ;
Bukowski, Ronald M. .
CANCER, 2007, 110 (03) :543-550
[6]   Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma [J].
Crispen, Paul L. ;
Sheinin, Yuri ;
Roth, Timothy J. ;
Lohse, Christine M. ;
Kuntz, Susan M. ;
Frigola, Xavier ;
Thompson, R. Houston ;
Boorjian, Stephen A. ;
Dong, Haidong ;
Leibovich, Bradley C. ;
Blute, Michael L. ;
Kwon, Eugene D. .
CLINICAL CANCER RESEARCH, 2008, 14 (16) :5150-5157
[7]   Predicting disease progression after nephrectomy for localized renal cell carcinoma: The utility of prognostic models and molecular biomarkers [J].
Crispen, Paul L. ;
Boorjian, Stephen A. ;
Lohse, Christine M. ;
Leibovich, Bradley C. ;
Kwon, Eugene D. .
CANCER, 2008, 113 (03) :450-460
[8]   Immune cells as mediators of solid tumor metastasis [J].
DeNardo, David G. ;
Johansson, Magnus ;
Coussens, Lisa M. .
CANCER AND METASTASIS REVIEWS, 2008, 27 (01) :11-18
[9]   Monocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma - results from a randomised phase II trial [J].
Donskov, F ;
Hokland, M ;
Marcussen, N ;
Madsen, HHT ;
von der Maase, H .
BRITISH JOURNAL OF CANCER, 2006, 94 (02) :218-226
[10]   Impact of immune parameters on long-term survival in metastatic renal cell carcinoma [J].
Donskov, F ;
von der Maase, H .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :1997-2005